Study Code: GWCA0999; EudraCT Number: 2009-016529-32; A multicenter, non-comparative, open-label extension study to assess the long term safety of Sativex oromucosal spray (Sative; Nabiximols) as adjunctive therapy in patients with uncontrolled persist

  • Markowitz, Avi, (PI)

    Project: Other project

    StatusFinished
    Effective start/end date4/24/124/23/15

    Funding

    • GW Pharmaceuticals: $9,376.00